Jeffrey W Bird - Net Worth and Insider Trading
Jeffrey W Bird Net Worth
The estimated net worth of Jeffrey W Bird is at least $751 Million dollars as of 2024-04-25. Jeffrey W Bird is the Director of Forty Seven Inc and owns about 3,876,666 shares of Forty Seven Inc (FTSV) stock worth over $370 Million. Jeffrey W Bird is the Director of Horizon Therapeutics PLC and owns about 3,028,304 shares of Horizon Therapeutics PLC (HZNP) stock worth over $352 Million. Jeffrey W Bird is also the Director of Portola Pharmaceuticals Inc and owns about 1,425,065 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $26 Million. Besides these, Jeffrey W Bird also holds Mattersight Corp (MATR) , Molecular Templates Inc (MTEM) . Details can be seen in Jeffrey W Bird's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey W Bird has not made any transactions after 2019-07-22 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey W Bird
Jeffrey W Bird Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey W Bird owns 11 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Forty Seven Inc (FTSV) , and Venus Concept Inc (VERO) among others .
Click here to see the complete history of Jeffrey W Bird’s form 4 insider trades.
Insider Ownership Summary of Jeffrey W Bird
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
FTSV | Forty Seven Inc | 2020-04-07 | director |
VERO | Venus Concept Inc | 2018-06-13 | director |
PSTG | Pure Storage Inc | 2015-10-06 | 10 percent owner |
YEXT | Yext Inc | 2017-04-12 | 10 percent owner |
MATR | Mattersight Corp | 2017-06-01 | 10 percent owner |
MTEM | Molecular Templates Inc | 2017-06-01 | 10 percent owner |
HZNP | Horizon Therapeutics PLC | 2013-12-13 | director |
DXTRQ | Dex Liquidating Co | 2013-03-20 | 10 percent owner |
CORT | Corcept Therapeutics Inc | 2009-10-16 | 10 percent owner |
QNST | QuinStreet Inc | 2010-02-10 | 10 percent owner |
Jeffrey W Bird Latest Holdings Summary
Jeffrey W Bird currently owns a total of 5 stocks. Among these stocks, Jeffrey W Bird owns 3,876,666 shares of Forty Seven Inc (FTSV) as of July 22, 2019, with a value of $370 Million and a weighting of 49.27%. Jeffrey W Bird owns 3,028,304 shares of Horizon Therapeutics PLC (HZNP) as of December 13, 2013, with a value of $352 Million and a weighting of 46.87%. Jeffrey W Bird also owns 1,425,065 shares of Portola Pharmaceuticals Inc (PTLA) as of August 23, 2018, with a value of $26 Million and a weighting of 3.42%. The other 2 stocks Mattersight Corp (MATR) , Molecular Templates Inc (MTEM) have a combined weighting of 0.45% among all his current holdings.
Latest Holdings of Jeffrey W Bird
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FTSV | Forty Seven Inc | 2019-07-22 | 3,876,666 | 95.51 | 370,260,370 |
HZNP | Horizon Therapeutics PLC | 2013-12-13 | 3,028,304 | 116.30 | 352,191,755 |
PTLA | Portola Pharmaceuticals Inc | 2018-08-23 | 1,425,065 | 18.03 | 25,693,922 |
MATR | Mattersight Corp | 2017-06-01 | 1,236,591 | 2.68 | 3,307,881 |
MTEM | Molecular Templates Inc | 2017-06-01 | 26,177 | 1.69 | 44,242 |
Holding Weightings of Jeffrey W Bird
Jeffrey W Bird Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 1 transactions in Forty Seven Inc (FTSV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Forty Seven Inc is the acquisition of 750,000 shares on July 22, 2019, which cost Jeffrey W Bird around $6 Million.
According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 668,673 shares on December 13, 2013, which cost Jeffrey W Bird around $4 Million.
According to the SEC Form 4 filings, Jeffrey W Bird has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the acquisition of 390,000 shares on August 23, 2018, which cost Jeffrey W Bird around $10 Million.
More details on Jeffrey W Bird's insider transactions can be found in the Insider Trading History of Jeffrey W Bird table.Insider Trading History of Jeffrey W Bird
- 1
Jeffrey W Bird Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey W Bird's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey W Bird is 13.08%. GuruFocus also compares Jeffrey W Bird's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey W Bird within 3 months outperforms 9 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey W Bird's insider trading performs compared to the benchmark.
Performance of Jeffrey W Bird
Average Return
14.93%
Outperforming Transactions
47%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 9.63 | 13.08 | 38.91 | 14.93 | 34.06 | 30.62 |
Relative Return to S&P 500(%) | 8.25 | 12.82 | 33.56 | 2.55 | 22.13 | 19.53 |
Jeffrey W Bird Ownership Network
Ownership Network List of Jeffrey W Bird
Ownership Network Relation of Jeffrey W Bird
Jeffrey W Bird Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Jeffrey W Bird is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Jeffrey W Bird Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey W Bird. You might contact Jeffrey W Bird via mailing address: 755 Page Mill Rd Ste A-200, Palo Alto Ca 94304-1005.